CJC-1295: Head-to-Head Comparison | Feature | Sermorelin | CJC-1295 (no DAC) | CJC-1295 (with DAC) | |---|---|---|---| | Amino acid length | 29 | 29 (modified) | 29 (modified + albumin-binding) | | Half-life | ~10-20 min | ~30 min | ~6-8 days | | GH release pattern | Pulsatile | Pulsatile | Sustained (blunted pulsatility) | | FDA approval | Withdrawn 2008 | Never approved | Never approved | | Injection frequency | Daily (bedtime) | 1-3x daily | Once weekly | | IGF-1 rise (trial data) | ~30% (Corpas et al.) | Not isolated in RCT | ~2-10x GH (Jett et al.) | | Evidence level | Small RCT | Pharmacokinetic data | Phase II PK study | Frequently Asked Questions Frequently asked questions Can you combine Sermorelin and CJC-1295
Injection Procedure Pinch about a 1-inch fold of skin between thumb and forefinger [15]
In a study of 643 cardiac patients who underwent coronary angiography in Germany, those who died of heart attacks had much lower glutathione peroxidase levels than those who survived.14 In the end, what this means is that if we don't have enough glutathione to neutralize damage to our arteries, we are at increased risk of heart and vascular disease events
Consistent with the role of cholesterol in the regulation of membrane dynamics, cholesterol loading in mitochondrial membrane results in increased membrane order parameter and in the reduction in the activity of specific membrane carriers, i B via c-SRC and oxidant-dependent cell death
Some common immediate side effects may include swelling, bruising, pain, burning, itchy skin, and discomfort
The pharmacological opposition makes the combination less predictable
